Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

ABIGALE 1 MG-0.5 MG TABLET

estradiol and norethindrone acetate
$0.6672per EA

Strength

1; .5 mg/1; mg/1

Manufacturer

Xiromed LLC

NDC

70700033085

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

ESTRADIOL; NORETHINDRONE ACETATE

Approval Type

Generic (ANDA)

FDA Application

ANDA207261

On Market Since

1/29/2025

Pharmacological Classes

Estradiol Congeners
Estrogen Receptor Agonists
Estrogen
Progesterone Congeners
Progestin

Price History

1W

0.0%

1M

+1.3%

3M

-8.9%

6M

-2.6%

1Y

N/A

3Y

N/A

5Y

N/A

All

+6.5%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

ESTRADIOL 0.5 MG TABLET
Generic
00555089902•Teva Pharmaceuticals USA Inc.
$0.0585
per EA
ESTRADIOL 0.5 MG TABLET
Generic
24658070201•PuraCap Laboratories LLC
$0.0585
per EA
ESTRADIOL 0.5 MG TABLET
Generic
42806008701•Epic Pharma LLC
$0.0585
per EA
ESTRADIOL 0.5 MG TABLET
Generic
42806008705•Epic Pharma LLC
$0.0585
per EA
ESTRADIOL 0.5 MG TABLET
Generic
70954056410•ANI Pharmaceuticals, Inc.
$0.0585
per EA
ESTRADIOL 0.5 MG TABLET
Generic
72603027301•NorthStar Rx LLC
$0.0585
per EA
ESTRADIOL 1 MG TABLET
Generic
00555088602•Teva Pharmaceuticals USA Inc.
$0.0658
per EA
ESTRADIOL 1 MG TABLET
Generic
00555088604•Teva Pharmaceuticals USA Inc.
$0.0658
per EA
ESTRADIOL 1 MG TABLET
Generic
24658070301•PuraCap Laboratories LLC
$0.0658
per EA
ESTRADIOL 1 MG TABLET
Generic
24658070305•PuraCap Laboratories LLC
$0.0658
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy